featured
Impact of Systemic Sclerosis–Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Chest
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Impact of systemic sclerosis-associated interstitial lung disease with and without pulmonary hypertension on survival - a large cohort study of the German network for systemic sclerosis
Chest 2023 Aug 13;[EPub Ahead of Print], P Moinzadeh, F Bonella, M Oberste, J Weliwitage, N Blank, G Riemekasten, U Müller-Ladner, J Henes, E Siegert, C Günther, I Kötter, C Pfeiffer, M Schmalzing, G Zeidler, P Korsten, L Susok, A Juche, M Worm, I Jandova, J Ehrchen, C Sunderkötter, G Keyßer, A Ramming, T Schmeiser, A Kreuter, HM Lorenz, N Hunzelmann, M KreuterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.